BAM
CMD

Bruderman Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Bruderman Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,102
Closed -$123K – 393
2018
Q1 		$123K Buy
+1,102
New +$124K 0.03% 153

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Bruderman Asset Management's CMD Position: Q2 2018 in Review

Bruderman Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2018, closing a stake of 1,102 shares — an estimated $123K sold.

Bruderman Asset Management first reported a position in CMD in Q1 2018 and held it in 1 quarter. The position peaked at $123K in Q1 2018. 292 funds tracked by Wall St. Rank hold CMD as of Q2 2018.

  • Bruderman Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2018 after selling out during the quarter.
  • Bruderman Asset Management sold 1,102 Cantel Medical Corporation shares in Q2 2018, an estimated $123K.
  • Bruderman Asset Management first reported a position in Cantel Medical Corporation in Q1 2018 and held it in 1 quarter.
  • Bruderman Asset Management's Cantel Medical Corporation position peaked at $123K in Q1 2018.
  • 292 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2018.

Based on Bruderman Asset Management's 13F filing for Q2 2018, filed 15 Aug 2018.